Company Research Report: MAK-SYSTEM

Company Overview

• Name: MAK-SYSTEM

• Mission: Empower clinicians to improve patient outcomes and save lives through innovative healthcare software.

• Founded: 1984

• Founder(s): No information is available

• Key People:

• Frank Jaubert, Chief Executive Officer

• Romain Pollak, Chief Finance Officer

• Difa Niculescu, Chief Technology Officer

• Lisa Frisch, Chief People & Sustainability Officer

• Pascal Gilbert-Jeantet, Chief Delivery Officer

• Clement Glinkowski, Global Commercial Director

• Meriam Serhane, Global Client Experience Director

• Stéphane Sajot, Chief Operating Officer

• Damjan Manchevski, Strategic Account Director & General Manager Balkans

• Headquarters: United Kingdom

• Number of Employees: No information is available

• Revenue: No information is available

• Known For: Leading provider of advanced technological solutions for managing blood, plasma, tissue, and cell products in healthcare.

Products

eProgesa

• Description: A comprehensive, single technological solution for blood and plasma centers.

• Key Features:

• End-to-end automation and traceability

• Seamless collection, safer preparation, and efficient distribution

• Interfaces with hospital information systems, lab and manufacturing devices

PHS / eTraceLine

• Description: Integrated software for hospital transfusion management, laboratory services, and reference labs.

• Key Features:

• Robust tracking and utilization of blood components

• Automation of result-based reflex testing

• Improved patient safety through donor and recipient matching

• Integration with existing hospital systems

Cosmas / TCS

• Description: A digital platform for managing tissue, cell, and gene therapies.

• Key Features:

• Supports autologous and allogeneic therapy

• Manages the entire value chain from collection to infusion

• Integrates with EHR, MES, logistic providers

• CE-marked for EU market

eDRM

• Description: Donor relationship management software aimed at enhancing donor recruitment and retention.

• Key Features:

• Digital automation of donor recruitment and management

• Highly configurable for varied deployment scales

• Integration with blood or plasma management solutions

MAK.care

• Description: A cloud-based global platform offering managed services for blood and biological products.

• Key Features:

• Transferred risk for digital ecosystem management

• Built-in security with 24/7 global managed Security Operations Center

• Compliance with healthcare security and privacy frameworks

• Scalable and resilient infrastructure

Recent Developments

New Launches

• MAK.care: Launched in 2022, it serves as the first global platform for blood and biologics, ensuring secure, end-to-end automation of blood donation operations.

Key Updates

• eProgesa v5.0.3: Received 510(k) clearance from the FDA, including cloud hosting capabilities with MAK.Care, allowing promotion and sales in the U.S.

• Cosmas: CE-marked and registered for the EU market, supporting the implementation of digital solutions for tissue, stem cell, and gene therapies.

Partnerships

• Northern Ireland Blood Transfusion Service Partnership (2024): Implementing a new "vein to vein" management system to enhance patient care and streamline the blood supply chain.

• New Zealand Blood Service (2024): Went live with MAK.care for fully managed, cloud-based nationwide blood donation operations.

• Amazon Web Services (2023): Strategic partnership to enhance digital ecosystems with AWS cloud solutions.

Industry Engagement

• International Events: Participation in AABB 23 in Nashville and speaking engagements at the International Transfusion Medicine Congress, focusing on digital transformation in blood transfusion.

This structured report offers a comprehensive overview of MAK-SYSTEM, highlighting its core products, recent developments, and strategic direction within the healthcare software industry.